AI Medical Compendium Journal:
JAMA oncology

Showing 11 to 20 of 22 articles

Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer.

JAMA oncology
IMPORTANCE: Machine learning (ML) algorithms can identify patients with cancer at risk of short-term mortality to inform treatment and advance care planning. However, no ML mortality risk prediction algorithm has been prospectively validated in oncol...

Use of Natural Language Processing to Assess Frequency of Functional Status Documentation for Patients Newly Diagnosed With Colorectal Cancer.

JAMA oncology
This cross-sectional study applies natural language processing to electronic health records from a large health care delivery system to examine performance status documentation among patients newly diagnosed with colorectal cancer.

External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms.

JAMA oncology
IMPORTANCE: A computer algorithm that performs at or above the level of radiologists in mammography screening assessment could improve the effectiveness of breast cancer screening.

Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care.

JAMA oncology
IMPORTANCE: Diagnosing the site of origin for cancer is a pillar of disease classification that has directed clinical care for more than a century. Even in an era of precision oncologic practice, in which treatment is increasingly informed by the pre...

Use of Crowd Innovation to Develop an Artificial Intelligence-Based Solution for Radiation Therapy Targeting.

JAMA oncology
IMPORTANCE: Radiation therapy (RT) is a critical cancer treatment, but the existing radiation oncologist work force does not meet growing global demand. One key physician task in RT planning involves tumor segmentation for targeting, which requires s...

Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning.

JAMA oncology
This study reports proof-of-principle early detection of chemotherapeutic-associated skin adverse drug reactions from social health networks using a deep learning–based signal generation pipeline to capture how patients describe cutaneous eruptions.